Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Genomic Loss of Tumor Suppressor miRNA-204 Promotes Cancer Cell Migration and Invasion by Activating AKT/mTOR/Rac1 Signaling and Actin Reorganization

Open access
Imam, J. Saadi, Plyler, Jason R., Bansal, Hima, Prajapati, Suresh, Bansal, Sanjay, Rebeles, Jennifer, Chen, Hung-I Harry, Chang, Yao-Fu, Panneerdoss, Subbarayalu, Zoghi, Behyar, Buddavarapu, Kalyan C., Broaddus, Russell, Hornsby, Peter, Tomlinson, Gail, Dome, Jeffrey, Vadlamudi, Ratna K., Pertsemlidis, Alexander, Chen, Yidong, Rao, Manjeet K.·2012·PLoS ONE

Abstract

Increasing evidence suggests that chromosomal regions containing microRNAs are functionally important in cancers. Here, we show that genomic loci encoding miR-204 are frequently lost in multiple cancers, including ovarian cancers, pediatric renal tumors, and breast cancers. MiR-204 shows drastically reduced expression in several cancers and acts as a potent tumor suppressor, inhibiting tumor metastasis in vivo when systemically delivered. We demonstrated that miR-204 exerts its function by targeting genes involved in tumorigenesis including brain-derived neurotrophic factor (BDNF), a neurotrophin family member which is known to promote tumor angiogenesis and invasiveness. Analysis of primary tumors shows that increased expression of BDNF or its receptor tropomyosin-related kinase B (TrkB) parallel a markedly reduced expression of miR-204. Our results reveal that loss of miR-204 results in BDNF overexpression and subsequent activation of the small GTPase Rac1 and actin reorganization through the AKT/mTOR signaling pathway leading to cancer cell migration and invasion. These results suggest that microdeletion of genomic loci containing miR-204 is directly linked with the deregulation of key oncogenic pathways that provide crucial stimulus for tumor growth and metastasis. Our findings provide a strong rationale for manipulating miR-204 levels therapeutically to suppress tumor metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0052397

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 158

Metadata

Authors
Imam, J. S., Plyler, J. R., Bansal, H., Prajapati, S., Bansal, S., Rebeles, J., Chen, H.-I. H., Chang, Y.-F., Panneerdoss, S., Zoghi, B., Buddavarapu, K. C., Broaddus, R., Hornsby, P., Tomlinson, G., Dome, J., Vadlamudi, R. K., Pertsemlidis, A., Chen, Y., & Rao, M. K.
Venue
PLoS ONE
Published
2012-12-21
Volume
7
Issue
12
Pages
e52397
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2122074931
Cited by
158
References
3
FWCI
4.62
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genomic Loss of Tumor Suppressor miRNA-204 Promotes Cancer Cell Migration and Invasion by Activating AKT/mTOR/Rac1 Signaling and Actin Reorganization. https://app.cochat.ai/papers/10.1371/journal.pone.0052397
The paper
Imam, J. S., Plyler, J. R., Bansal, H., Prajapati, S., Bansal, S., Rebeles, J., Chen, H.-I. H., Chang, Y.-F., Panneerdoss, S., Zoghi, B., Buddavarapu, K. C., Broaddus, R., Hornsby, P., Tomlinson, G., Dome, J., Vadlamudi, R. K., Pertsemlidis, A., Chen, Y., & Rao, M. K. (2012). Genomic Loss of Tumor Suppressor miRNA-204 Promotes Cancer Cell Migration and Invasion by Activating AKT/mTOR/Rac1 Signaling and Actin Reorganization. PLoS ONE. https://doi.org/10.1371/journal.pone.0052397

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.